Budesonide for the Induction and Maintenance of Remission in Crohn’s Disease: Systematic Review and Meta-Analysis for the Cochrane Collaboration

BACKGROUND: Budesonide is an oral glucocorticoid designed for the treatment of inflammatory bowel disease (IBD) that may reduce systemic adverse events (AEs). This review examined the efficacy and safety of budesonide for the induction and maintenance of clinical remission in Crohn’s disease (CD). M...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Can Assoc Gastroenterol
Main Authors: Kuenzig, M Ellen, Rezaie, Ali, Kaplan, Gilaad G, Otley, Anthony R, Steinhart, A Hillary, Griffiths, Anne Marie, Benchimol, Eric I, Seow, Cynthia H
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6328928/
https://ncbi.nlm.nih.gov/pubmed/30656288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy018
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados